Alnylam Pharmaceuticals Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) Transcript
Hey, everybody. It's Alethia Young. I cover large cap, small, mid-cap biotech here at Cantor. Happy to have Alnylam Pharmaceuticals here with me. I have Jeff Poulton, who's the CFO of the company, and we'll do a fireside chat for 30 minutes. And we're going to just dive right on then since you guys have a lot of stuff going on.
Questions & Answers
I guess just one, which is a common question that's popped up, is just you have some commercial products. And just talk a little bit about the COVID impact on the business for ONPATTRO and GIVLAARI. And maybe some of the similarities and differences of COVID impacts between those 2 programs and different indications.
Sure. Welcome. It's nice to be here. Let me remind you, first, what we shared on our Q1 call, which
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
